Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...
Cystic acne is a severe form of acne in which large, painful cysts form deep under the skin, according to Dr. Fahs. It develops when oil and dead skin cells clog your pores, which triggers ...
Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...
This form of acne has proven to be more stubborn especially if past experiences have increased the skin's microbes resistant to treatment. Acne refers to the skin disease involving sebum, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results